SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001387131-21-003556
Filing Date
2021-03-15
Accepted
2021-03-15 16:50:36
Documents
3
Period of Report
2021-03-15
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT tnxp-8k_031521.htm 8-K 30264
2 PRESS RELEASE OF THE COMPANY, DATED MARCH 15, 2021 ex99-01.htm EX-99.01 68189
3 PRESS RELEASE OF THE COMPANY, DATED MARCH 15, 2021 ex99-02.htm EX-99.02 21206
  Complete submission text file 0001387131-21-003556.txt   120927
Mailing Address 28 MAIN STREET CHATHAM NJ 07928
Business Address 28 MAIN STREET CHATHAM NJ 07928 212-980-9155
Tonix Pharmaceuticals Holding Corp. (Filer) CIK: 0001430306 (see all company filings)

IRS No.: 261434750 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36019 | Film No.: 21742122
SIC: 2834 Pharmaceutical Preparations